1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B0435
    Roxithromycin

    罗红霉素

    Inhibitor 99.93%
    Roxithromycin (RU-28965) 是一种半合成的大环内酯类抗生素。Roxithromycin 通过与 50S 细菌核糖体结合,在延伸步骤中抑制蛋白质的生物合成。Roxithromycin 具有抑菌、抗增殖、抗炎、抑制肿瘤血管和改善肺损伤作用。
    Roxithromycin
  • HY-110247
    TRAF-STOP inhibitor 6877002 Inhibitor 99.67%
    TRAF-STOP inhibitor 6877002,一种抑制 CD40-TRAF6 相互作用的选择性抑制剂,从专利 WO2014033122A1 中获得,抑制 RAW 细胞中 NF-κB 活化,化合物VII。TRAF-STOP 6877002 可阻止小鼠中已发生的动脉粥样硬化恶化,减少白细胞募集并减少巨噬细胞活化;减少动脉粥样硬化斑块中的巨噬细胞增殖。
    TRAF-STOP inhibitor 6877002
  • HY-N6949
    Juglone

    胡桃醌

    Inhibitor 99.68%
    Juglone (5-Hydroxy-1,4-naphthalenedione) 是可从胡桃 Juglans regia 中提取的一种黄色染料。Juglone 通过线粒体途径诱导细胞凋亡。Juglone 具有抗菌、抗肿瘤活性。
    Juglone
  • HY-N6727
    Gliotoxin Inhibitor 99.51%
    Gliotoxin 是一种次生代谢产物,是 A. fumigatus 分泌的最丰富的霉菌毒素,抑制巨噬细胞的吞噬作用和其他免疫细胞的免疫功能。Gliotoxin 通过阻止 IκB 降解来抑制诱导型 NF-κB 活性,从而诱导宿主细胞凋亡 (apoptosis)。 Gliotoxin 可以激活 PKA 并增加细胞内 cAMP 浓度,调节肌动蛋白细胞骨架重排以促进 A. fumigatus 内化到肺上皮细胞。Gliotoxin 也是 NOTCH2 转录激活抑制剂,可有效诱导慢性淋巴细胞白血病 (CLL) 细胞凋亡。
    Gliotoxin
  • HY-152860
    Darizmetinib Activator 99.94%
    Darizmetinib 是具有口服活性,强效且选择性的有丝分裂激活蛋白激酶激酶 4 (MKK4) 抑制剂。Darizmetinib 能够增强 MKK7 和 JNK1 信号通路,从而激活转录因子 ATF2 和 ELK1,促进细胞增殖和肝脏再生。Darizmetinib 有望用于防止广泛的肿瘤肝切除术后或小肝移植后的肝功能衰竭的研究。
    Darizmetinib
  • HY-N0474
    Tyrosol

    酪醇

    Inhibitor 99.98%
    Tyrosol 是苯乙醇的衍生物。Tyrosol 减弱来自星形胶质细胞的促炎细胞因子,且降低 NF-κB 活化。具有抗氧化和抗炎作用。
    Tyrosol
  • HY-N1380
    Guaiacol

    愈创木酚

    Inhibitor 99.73%
    Guaiacol 是一种酚类化合物,抑制 LPS 刺激的 COX-2 表达和 NF-κB 激活。具有抗炎活性。
    Guaiacol
  • HY-N0043
    Ginsenoside Rd

    人参皂苷 Rd

    Inhibitor 99.88%
    Ginsenoside Rd 抑制 TNFα 诱导的 NF-κB 转录活性,IC50 为 12.05±0.82 μM。Ginsenoside Rd 抑制 COX-2iNOS mRNA 的表达。Ginsenoside Rd 还抑制 Ca2+ 内流。Ginsenoside Rd 抑制CYP2D6CYP1A2CYP3A4CYP2C9IC50 分别为 58.0±4.5 μM,78.4±5.3 μM,81.7±2.6 μM 和 85.1±9.1 μM。
    Ginsenoside Rd
  • HY-W012977
    3,3-Dimethyl-1-butanol

    新己醇

    Inhibitor 99.56%
    3,3-Dimethyl-1-butanol (DMB) 是一种口服有效的三甲胺 (TMA) 和三甲基胺-N-氧化物 (TMAO) 抑制剂。3,3-Dimethyl-1-butanol 抑制 p65 NF-κBTGF-β1/Smad3 信号通路。3,3-Dimethyl-1-butanol 在心血管疾病 (CVD) 中有潜在应用。
    3,3-Dimethyl-1-butanol
  • HY-18935
    CBL0137 Inhibitor 99.68%
    CBL0137 是一种 curaxin 化合物,是一种组蛋白伴侣促进染色质转录 (FACT) 抑制剂。CBL0137 下调 NF-?B 并激活 p53。CBL0137 可恢复组蛋白 H3 乙酰化和三甲基化。CBL0137 是一种抗癌剂。CBL0137 诱导癌细胞凋亡 (apoptosis)。
    CBL0137
  • HY-N0755
    Rhoifolin

    野漆树苷

    Activator 99.09%
    Rhoifolin 是一种黄酮糖苷,可从野洋漆分离。 Rhoifolin 通过增强脂联素分泌、胰岛素受体-β (insulin receptor-β) 的酪氨酸磷酸化和 GLUT4 易位来发挥抗糖尿病作用。Rhoifolin 通过对炎症介质的多层次调控发挥抗炎作用。Rhoifolin 通过 RANKL 诱导的 NF-κBMAPK 途径改善钛颗粒刺激的骨溶解并减弱破骨细胞生成。Rhoifolin 对多种癌细胞系也具有细胞毒性活性。
    Rhoifolin
  • HY-N8518
    Malabaricone C Inhibitor 99.61%
    Malabaricone C 是一种具有口服活性的非竞争性鞘磷脂合成酶 (SMS) 抑制剂,IC50 值在 SMS 1 和 SMS 2 中分别为 3 μM 和 1.5 μM。Malabaricone C 降低小鼠体重增加,提高葡萄糖耐量,减少肝脏脂质积累,对高脂肪饮食诱导的脂肪肝有显著的预防作用。Malabaricone C 具有抗炎作用,发现于 Myristica cinnamomea King的果实中。Malabaricone C 有望用于肥胖和由 T 细胞过度激活而引起的免疫性疾病的研究。
    Malabaricone C
  • HY-100594
    EUK-134 Inhibitor 98.08%
    EUK-134 是一种合成的超氧化物歧化酶和过氧化氢酶模拟物,可保护大鼠肾脏免受缺血再灌注引起的损伤。EUK-134 是一种具有过氧化氢酶活性的超氧化物歧化酶 (SOD) 模拟物 (SODm)。EUK-134 是一种保护有丝分裂的抗氧化剂。EUK-134 作用于 H9C2 细胞,降低 NF-κB 表达、MDA 水平和蛋白质羰基化。
    EUK-134
  • HY-D0939
    Direct Blue 1 Inhibitor
    Direct Blue 1 (Chicago Sky Blue 6B) 是免疫荧光组织化学中背景自体荧光的一种复染料。Direct Blue 1是一种有效且具有竞争性的 VGLUT 抑制剂。Direct Blue 1 能够抑制 Aβ 结合的小分子 PrP 配体。Direct Blue 1 具有抗炎活性。
    Direct Blue 1
  • HY-N0387
    Rhynchophylline

    钩藤碱

    Inhibitor 99.94%
    钩藤碱 (Rhyncholphylline)是从钩藤中分离到的一种生物碱类化合物。钩藤碱是一种 EphA4 抑制剂。钩藤碱具有很高的生物活性,被广泛用于抗炎、神经保护等方面的研究。
    Rhynchophylline
  • HY-N0213
    Peiminine

    贝母素乙

    99.94%
    Peiminine 是一种可以从南瓜科 Bolbostemma paniculatum (Maxim) Franquet 中分离得到的化合物。Peiminin 可通过内源性和外源性凋亡途径诱导人肝癌 HepG2 细胞凋亡(apoptosis)。在许多动物模型中,Peiminin 具有抗炎、抗癌、抗骨质疏松、心肌保护等活性。
    Peiminine
  • HY-N6673
    Okanin

    奥卡宁

    Inhibitor 99.98%
    Okanin 是 Coreopsis tinctoria 的有效成分。Okanin 通过抑制 TLR4/NF-κB 信号通路减弱 LPS 诱导的小胶质细胞活化。
    Okanin
  • HY-108694
    γ-Tocotrienol Inhibitor 99.73%
    γ-Tocotrienol 是维生素 E 的一种活性形式。γ-Tocotrienol 能够作用 NF-κB 和 P-gp 信号通路来逆转乳腺癌细胞多药耐药性 (MDR)。γ-Tocotrienol 也是一种新型的放射性保护剂,可减轻放射性核素靶向治疗时对骨髓的辐射损伤。
    γ-Tocotrienol
  • HY-126741
    Azadirachtin

    印楝素

    Inhibitor 99.06%
    Azadirachtin 是一种具有口服活性的三萜类化合物,具有抗癌、抗疟疾、抗炎、杀虫活性。Azadirachtin 通过线粒体通路 (抑制 Bcl-2/Bax 和死亡受体 (TNFR),激活 Apaf-1caspase-3))的参与诱导细胞凋亡 (Apoptosis)。同时,Azadirachtin 通过抑制 NF-кB信号通路激活发挥抗炎作用,以及通过诱导昆虫细胞凋亡发挥抗虫害功能。
    Azadirachtin
  • HY-N6607
    Tryptanthrin Inhibitor 99.89%
    Tryptanthrin 是一种吲哚喹唑啉,可以是产自靛蓝植物的生物碱。Tryptanthrin 是一种口服有效的细胞白三烯 (LT) 生物合成抑制剂。Tryptanthrin 具有抗癌活性。Tryptanthrin 可抑制 NOS1、COX-2、NF-κB 的表达水平,调节 IL-2、IL-10、TNF-α 的表达水平。
    Tryptanthrin
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.